Minimally Invasive Delivery of Therapeutic Cells to Abdominal Aortic Aneurysm




7-10% of US males are affected by abdominal aortic aneurysm, a focal balloon-like dilatation of the distal aorta. A rupture is life-threatening, being 13th leading cause of death in the US. Large aneurysms can be treated with surgery, but there is no existing treatment for small aneurysms, which grow over time. The team is working on a localized delivery of therapeutic cells that will induce healing of the small abdominal aortic aneurysms—preventing or delaying surgery.